Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Interleukin-6 may play a role in causing alopecia areata.

UC.145 may be a new biomarker for predicting gastric cancer.

Overexpression of ΔNLef1 in mouse skin leads to hair loss, cysts, and skin tumors.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

These gene variations are not linked to alopecia areata in Egyptians.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The study was retracted.

Targeting IL-17 could help treat pattern hair loss.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Lygodium japonicum spores can reduce inflammation by blocking certain cell signals.

CDP is crucial for lung and hair follicle cell development.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

LRIG1 is linked to better survival in Merkel cell carcinoma.

TNF-alpha inhibitors can cause various immune-related skin issues.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Sintilimab treatment caused hair loss but led to complete tumor remission.